![Carlos Hernández Sande](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carlos Hernández Sande
Directeur Général chez
Uninvest SGEIC SA
Profil
Carlos Hernández Sande is currently the Chief Executive Officer at Unirisco Galicia and the Managing Director at Uninvest SGEIC SA since 2011.
He previously worked as a Secretary at Genomix Genetics & Health SL.
Postes actifs de Carlos Hernández Sande
| Sociétés | Poste | Début |
|---|---|---|
Uninvest SGEIC SA
 Uninvest SGEIC SA Investment ManagersFinance Uninvest seeks investment opportunities in companies located in Spain. The firm targets businesses operating mainly in the technology sector such as agri-food, industrial biotechnology, and health technologies. It provides equity financing for seed and early stage capital requirements. | Directeur Général | - |
Unirisco Galicia
 Unirisco Galicia Investment ManagersFinance UNIRISCO is an active manager which invests in innovative technology projects based on research from the universities of Santiago and Vigo in all sectors except finance. They focus their investments in Spain, Northern Portugal and the Galicia region, particularly in areas where the universities of Santiago and Vigo have a socio-economic impact. Other areas are taken into consideration, provided they are of socio-economic benefit to Galicia. The firm selects investments through the University of Santiago's business promotion group, UNINOVA, seeking to invest EUR 100,000-300,000 in companies with a capable management team, an innovative business project, significant growth and profitability prospects and a stable and verifiable business plan. They typically invest up to EUR 450,000 as sole investor and co-invest in syndication with venture capital partners for larger amounts. UNIRISCO takes minority stakes and a seat on the board of directors in the companies in which they participate, partnering with the investee company to help them develop a market for their products and provide them with national and international contacts. The firm generally holds an investment for three to ten years, preferring to exit through a sale to the investee company's original shareholders. | Directeur Général | - |
Anciens postes connus de Carlos Hernández Sande
| Sociétés | Poste | Fin |
|---|---|---|
Genomix Genetics & Health SL
 Genomix Genetics & Health SL Medical SpecialtiesHealth Technology Develops and manufactures diagnostic products | Secrétaire Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Unirisco Galicia
Unirisco Galicia Investment ManagersFinance UNIRISCO is an active manager which invests in innovative technology projects based on research from the universities of Santiago and Vigo in all sectors except finance. They focus their investments in Spain, Northern Portugal and the Galicia region, particularly in areas where the universities of Santiago and Vigo have a socio-economic impact. Other areas are taken into consideration, provided they are of socio-economic benefit to Galicia. The firm selects investments through the University of Santiago's business promotion group, UNINOVA, seeking to invest EUR 100,000-300,000 in companies with a capable management team, an innovative business project, significant growth and profitability prospects and a stable and verifiable business plan. They typically invest up to EUR 450,000 as sole investor and co-invest in syndication with venture capital partners for larger amounts. UNIRISCO takes minority stakes and a seat on the board of directors in the companies in which they participate, partnering with the investee company to help them develop a market for their products and provide them with national and international contacts. The firm generally holds an investment for three to ten years, preferring to exit through a sale to the investee company's original shareholders. | Finance |
Uninvest SGEIC SA
Uninvest SGEIC SA Investment ManagersFinance Uninvest seeks investment opportunities in companies located in Spain. The firm targets businesses operating mainly in the technology sector such as agri-food, industrial biotechnology, and health technologies. It provides equity financing for seed and early stage capital requirements. | Finance |
Genomix Genetics & Health SL
Genomix Genetics & Health SL Medical SpecialtiesHealth Technology Develops and manufactures diagnostic products | Health Technology |
Choisissez Zonebourse 
